- Home
- KXIN vs LIPO Comparison
KXIN vs LIPO Comparison
Compare KXIN & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KXIN
- LIPO
- Stock Information
- Founded
- KXIN 2015
- LIPO 2005
- Country
- KXIN China
- LIPO United States
- Employees
- KXIN N/A
- LIPO N/A
- Industry
- KXIN Retail-Auto Dealers and Gas Stations
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- KXIN Consumer Discretionary
- LIPO Health Care
- Exchange
- KXIN Nasdaq
- LIPO Nasdaq
- Market Cap
- KXIN 2.8M
- LIPO 3.1M
- IPO Year
- KXIN N/A
- LIPO 2022
- Fundamental
- Price
- KXIN $1.28
- LIPO $3.14
- Analyst Decision
- KXIN
- LIPO Strong Buy
- Analyst Count
- KXIN 0
- LIPO 1
- Target Price
- KXIN N/A
- LIPO $16.00
- AVG Volume (30 Days)
- KXIN 266.9K
- LIPO 6.6M
- Earning Date
- KXIN 01-01-0001
- LIPO 02-28-2025
- Dividend Yield
- KXIN N/A
- LIPO N/A
- EPS Growth
- KXIN N/A
- LIPO N/A
- EPS
- KXIN N/A
- LIPO N/A
- Revenue
- KXIN $12,679,000.00
- LIPO $483,533.00
- Revenue This Year
- KXIN N/A
- LIPO N/A
- Revenue Next Year
- KXIN N/A
- LIPO N/A
- P/E Ratio
- KXIN N/A
- LIPO N/A
- Revenue Growth
- KXIN N/A
- LIPO 0.78
- 52 Week Low
- KXIN $1.20
- LIPO $2.21
- 52 Week High
- KXIN $29.52
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- KXIN 39.34
- LIPO 48.05
- Support Level
- KXIN $1.21
- LIPO $3.35
- Resistance Level
- KXIN $1.44
- LIPO $4.69
- Average True Range (ATR)
- KXIN 0.09
- LIPO 0.62
- MACD
- KXIN 0.01
- LIPO -0.02
- Stochastic Oscillator
- KXIN 29.17
- LIPO 13.31
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.